Literature DB >> 24812060

The TLR signaling adaptor TRAM interacts with TRAF6 to mediate activation of the inflammatory response by TLR4.

Brett Verstak1, Julianne Stack2, Thomas Ve3, Matthew Mangan4, Kathryn Hjerrild4, Jannah Jeon3, Rainer Stahl5, Eicke Latz6, Nick Gay7, Bostjan Kobe3, Andrew G Bowie2, Ashley Mansell8.   

Abstract

TLRs act as sentinels in professional immune cells to detect and initiate the innate immune response to pathogen challenge. TLR4 is a widely expressed TLR, responsible for initiating potent immune responses to LPS. TRAM acts to bridge TLR4 with TRIF, orchestrating the inflammatory response to pathogen challenge. We have identified a putative TRAF6-binding motif in TRAM that could mediate a novel signaling function for TRAM in TLR4 signaling. TRAM and TRAF6 association was confirmed by immunoprecipitation of endogenous, ectopically expressed and recombinant proteins, which was ablated upon mutation of a key Glu residue in TRAM (TRAM E183A). TRAF6 and TRAM were observed colocalizing using confocal microscopy following ectopic expression in cells and the ability of TRAM and TRAM E183A to activate luciferase-linked reporter assays was determined in HEK293 and TRAF6-deficient cells. Importantly, TRAM-deficient macrophages reconstituted with TRAM E183A display significantly reduced inflammatory TNF-α, IL-6, and RANTES protein production compared with WT TRAM. These results demonstrate a novel role for TRAM in TLR4-mediated signaling in regulating inflammatory responses via its interaction with TRAF6, distinct from its role as a bridging adaptor between TLR4 and TRIF.
© 2014 Society for Leukocyte Biology.

Entities:  

Keywords:  Toll-like receptors; inflammation; innate immunity; signal transduction

Mesh:

Substances:

Year:  2014        PMID: 24812060      PMCID: PMC4632169          DOI: 10.1189/jlb.2A0913-487R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  42 in total

1.  Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter.

Authors:  T Agalioti; S Lomvardas; B Parekh; J Yie; T Maniatis; D Thanos
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

2.  Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Hideki Sanjo; Satoshi Uematsu; Tsuneyasu Kaisho; Katsuaki Hoshino; Osamu Takeuchi; Masaya Kobayashi; Takashi Fujita; Kiyoshi Takeda; Shizuo Akira
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

Review 3.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

4.  Regulation of lipopolysaccharide-induced translation of tumor necrosis factor-alpha by the toll-like receptor 4 adaptor protein TRAM.

Authors:  Lijian Wang; Estela Trebicka; Ying Fu; Lisa Waggoner; Shizuo Akira; Katherine A Fitzgerald; Jonathan C Kagan; Bobby J Cherayil
Journal:  J Innate Immun       Date:  2011-04-14       Impact factor: 7.349

5.  The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.

Authors:  Michael Carty; Rory Goodbody; Martina Schröder; Julianne Stack; Paul N Moynagh; Andrew G Bowie
Journal:  Nat Immunol       Date:  2006-09-10       Impact factor: 25.606

6.  MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses.

Authors:  Brett Verstak; Kamalpreet Nagpal; Stephen P Bottomley; Douglas T Golenbock; Paul J Hertzog; Ashley Mansell
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

7.  TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Satoshi Uematsu; Katsuaki Hoshino; Tsuneyasu Kaisho; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira
Journal:  Nat Immunol       Date:  2003-10-12       Impact factor: 25.606

8.  Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.

Authors:  Shintaro Sato; Masanaka Sugiyama; Masahiro Yamamoto; Yasuyuki Watanabe; Taro Kawai; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

Review 9.  Adaptors in toll-like receptor signaling and their potential as therapeutic targets.

Authors:  Thomas Ve; Nicholas J Gay; Ashley Mansell; Bostjan Kobe; Stuart Kellie
Journal:  Curr Drug Targets       Date:  2012-10       Impact factor: 3.465

10.  Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection.

Authors:  Eugene Valkov; Anna Stamp; Frank Dimaio; David Baker; Brett Verstak; Pietro Roversi; Stuart Kellie; Matthew J Sweet; Ashley Mansell; Nicholas J Gay; Jennifer L Martin; Bostjan Kobe
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

View more
  13 in total

1.  Artemisinin Attenuates Amyloid-Induced Brain Inflammation and Memory Impairments by Modulating TLR4/NF-κB Signaling.

Authors:  Xia Zhao; Xiaosu Huang; Chao Yang; Yizhou Jiang; Wenshu Zhou; Wenhua Zheng
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

2.  MiR-27a ameliorates inflammatory damage to the blood-spinal cord barrier after spinal cord ischemia: reperfusion injury in rats by downregulating TICAM-2 of the TLR4 signaling pathway.

Authors:  Xiao-Qian Li; Huang-Wei Lv; Zhi-Lin Wang; Wen-Fei Tan; Bo Fang; Hong Ma
Journal:  J Neuroinflammation       Date:  2015-02-07       Impact factor: 8.322

3.  Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo.

Authors:  Lijing Zhou; Zijing Liu; Zhixue Wang; Shuang Yu; Tingting Long; Xing Zhou; Yixi Bao
Journal:  Sci Rep       Date:  2017-03-17       Impact factor: 4.379

Review 4.  Progressive Skeletal Muscle Atrophy in Muscular Dystrophies: A Role for Toll-like Receptor-Signaling in Disease Pathogenesis.

Authors:  Boel De Paepe
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

5.  TRAF6 Plays a Proviral Role in Tick-Borne Flavivirus Infection through Interaction with the NS3 Protease.

Authors:  Brian H Youseff; Thomas G Brewer; Kristin L McNally; Adaeze O Izuogu; Kirk J Lubick; John B Presloid; Saad Alqahtani; Saurabh Chattopadhyay; Sonja M Best; Xiche Hu; R Travis Taylor
Journal:  iScience       Date:  2019-05-11

6.  Polarization of Low-Grade Inflammatory Monocytes Through TRAM-Mediated Up-Regulation of Keap1 by Super-Low Dose Endotoxin.

Authors:  Allison Rahtes; Liwu Li
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

Review 7.  Trametes versicolor (Synn. Coriolus versicolor) Polysaccharides in Cancer Therapy: Targets and Efficacy.

Authors:  Solomon Habtemariam
Journal:  Biomedicines       Date:  2020-05-25

8.  A mathematical model relates intracellular TLR4 oscillations to sepsis progression.

Authors:  Razvan C Stan; Francisco G Soriano; Maristela M de Camargo
Journal:  BMC Res Notes       Date:  2018-07-11

Review 9.  Poxviral Targeting of Interferon Regulatory Factor Activation.

Authors:  Clara Lawler; Gareth Brady
Journal:  Viruses       Date:  2020-10-20       Impact factor: 5.048

Review 10.  Toll-Like Receptor as a Potential Biomarker in Renal Diseases.

Authors:  Sebastian Mertowski; Paulina Lipa; Izabela Morawska; Paulina Niedźwiedzka-Rystwej; Dominika Bębnowska; Rafał Hrynkiewicz; Ewelina Grywalska; Jacek Roliński; Wojciech Załuska
Journal:  Int J Mol Sci       Date:  2020-09-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.